Clinical Outcomes of Parenteral Methylene Blue as Adjunct Therapy in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
Background: During the pandemic, methylene blue emerged as a repurposed drug for the treatment of COVID-19. The objective was to evaluate clinical outcomes of parenteral methylene blue use in hospitalized COVID-19 patients. Methodology: A retrospective cohort study was conducted at COVID-19 hospitals in Rajkot, during...